 Effect valproate human cerebral glucose metabolism effects valproate VPA local cerebral glucose metabolism LCMRglc patients partial seizure disorders primary generalized epilepsy patient positron-emission tomography PET FDG VPA mean level mg/dl mg/dl Patients carbamazepine CBZ scans serum concentrations VPA CBZ mg/dl Seven patients without-VPA scan Mean interval PET scans days Global CMRglc addition VPA g/min VPA g/min VPA Thirteen regions interest ROIs hemisphere PET scan Metabolic rates ROIs VPA VPA cerebral metabolism degree CBZ phenytoin PHT phenobarbital PB metabolic effect mechanism action neuropsychological implications